Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Oligomerization of members of the p53 family of transcription factors (p53, p63, and p73) is essential for their distinct functions in cell-cycle control and development. To elucidate the molecular basis for tetramer formation of the various family members, we solved the crystal structure of the hum...

Descripció completa

Dades bibliogràfiques
Autors principals:	Joerger, A, Rajagopalan, S, Natan, E, Veprintsev, D, Robinson, C, Fersht, A
Format:	Journal article
Idioma:	English
Publicat:	2009

Ítems similars

P63 and P73 Activation in Cancers with p53 Mutation
per: Bi-He Cai, et al.
Publicat: (2022-06-01)

Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration.
per: Arbely, E, et al.
Publicat: (2011)

Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.
per: Natan, E, et al.
Publicat: (2011)

A família do p53: aspectos estruturais e funcionais do p73 e do p63 The p53 family: structural and functional aspects of p73 and p63
per: Alfredo Ribeiro-Silva, et al.
Publicat: (2003-06-01)

Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
per: Robinson, R, et al.
Publicat: (2008)

Ultraslow oligomerization equilibria of p53 and its implications.
per: Natan, E, et al.
Publicat: (2009)

Oncogenic p53 triggers amyloid aggregation of p63 and p73 liquid droplets
per: Elaine C. Petronilho, et al.
Publicat: (2024-09-01)

The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.
per: Lakshmanane Boominathan
Publicat: (2010-05-01)

Stability of p53 homologs.
per: Tobias Brandt, et al.
Publicat: (2012-01-01)

Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization.
per: Gebel, J, et al.
Publicat: (2016)

Dynamic expression of the p53 family members p63 and p73 in the mouse and human telencephalon during development and in adulthood.
per: Hernández-Acosta, N, et al.
Publicat: (2011)

Dynamic expression of the p53 family members p63 and p73 in the mouse and human telencephalon during development and in adulthood
per: Hernández-Acosta, N, et al.
Publicat: (2011)

Functional regulation of p73 and p63: development and cancer.
per: Melino, G, et al.
Publicat: (2003)

Intrinsically disordered p53 and its complexes populate compact conformations in the gas phase.
per: Pagel, K, et al.
Publicat: (2013)

Rescuing the function of mutant p53.
per: Bullock, A, et al.
Publicat: (2001)

p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair
per: Lin, Yu-Li, et al.
Publicat: (2010)

DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma
per: Alexander Strubel, et al.
Publicat: (2023-10-01)

Retraction: p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair.
per: PLOS Genetics Editors
Publicat: (2023-03-01)

EXPRESSION OF p53 AND p63 IN CERVICAL SQUAMOUS CELL CARCINOMA
per: , ILHAMI ROMUS, et al.
Publicat: (2013)

Immunohistochemical expression of p63, p53 in urinary bladder carcinoma
per: Ali Koyuncuer
Publicat: (2013-01-01)

p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.
per: Lefkimmiatis, K, et al.
Publicat: (2009)

Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators
per: Dimitrios-Ilias Balourdas, et al.
Publicat: (2024-06-01)

Strategies to Discover p53 Activators and a p73 Activator for Neuroblastoma
per: Emília Sousa, et al.
Publicat: (2019-08-01)

MDM2 and MDMX bind and stabilize the p53-related protein p73
per: Ongkeko, W, et al.
Publicat: (1999)

Effect of hydroxyurea on the promoter occupancy profiles of tumor suppressor p53 and p73
per: Lu Xin, et al.
Publicat: (2009-06-01)

Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors.
per: Elena Zaika, et al.
Publicat: (2013-01-01)

Expression of p63, p53 and Ki-67 in Patients with Cervical Intraepithelial Neoplasia
per: Androniks MITILDZANS, et al.
Publicat: (2017-01-01)

Dissecting the DNA binding landscape and gene regulatory network of p63 and p53
per: Konstantin Riege, et al.
Publicat: (2020-12-01)

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.
per: Bergamaschi, D, et al.
Publicat: (2003)

Specific recognition of p53 tetramers by peptides derived from p53 interacting proteins.
per: Ronen Gabizon, et al.
Publicat: (2012-01-01)

A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.
per: Bell, H, et al.
Publicat: (2007)

Inactivation of the KcsA potassium channel explored with heterotetramers.
per: Rotem, D, et al.
Publicat: (2010)

Distinct p63 and p73 Protein Interactions Predict Specific Functions in mRNA Splicing and Polyploidy Control in Epithelia
per: Julian M. Rozenberg, et al.
Publicat: (2020-12-01)

Evaluation of P53 and P63 expression and their correlation with HPV virus in oral dysplastic lesions
per: Fatemeh Mashhadi Abbas, et al.
Publicat: (2012-01-01)

Revisiting the Dimensions of Knowledge Management Orientation Behavior in Indonesia Creative Industry (P.63-73)
per: Ananda Sabil Hussein, et al.
Publicat: (2017-02-01)

Assessment and comparison of p53 and p63 expression in oral epithelial dysplasia and squamous cell carcinoma
per: Smitha Sammith Shetty, et al.
Publicat: (2014-01-01)

Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer.
per: Zhongqiu Wang, et al.
Publicat: (2012-01-01)

Heterodimer-heterotetramer formation mediates enhanced sensor activity in a biophysical model for BMP signaling.
per: Md Shahriar Karim, et al.
Publicat: (2021-09-01)

Immunohistochemical analysis of dentigerous cyst and ameloblastoma using cytokeratin 19 & 14, p53, p63 and ki-67
per: K Sudheer Kanth, et al.
Publicat: (2012-01-01)

Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia
per: Jonas Sundberg, et al.
Publicat: (2021-10-01)